Samsung Bioepis' European Whitepaper Proposes Solutions to Bridge Policy Gaps that Hinder Healthy Market Competition and Timely

• click to rate

  Posted by Two Blokes Jul 14 - Filed in Stock - 5 views
  
  INCHEON, Korea--(BUSINESS WIRE)-- #biosimilars--Samsung Bioepis Co., Ltd. today published a whitepaper titled ‘Solving the Biosimilar Void in Europe' that proposes policy recommendations to fully recognize the value of biosimilars and ensure a more sustainable market in Europe. Biosimilars have played a significant role in alleviating the financial burden on the European healthcare system, having delivered €56 billion in cumulative cost savings across Europe over the past 11 years (2013-2024).1 However, the c.